跳至主要内容
临床试验/CTRI/2021/12/038779
CTRI/2021/12/038779已完成未知

Efficacy of digital therapeutic intervention via MAP (Mobile health Application Phablecare) in Indian adults with Uncontrolled Hypertension: A 12-week prospective single arm study. - MAP

Terrals Technologies Pvt Ltd0 个研究点目标入组 125 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
125

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Male or female patients aged ââ?°Â¥ 30 to 65 years.
  • 2.Able to give written informed consent.
  • 3.Diagnosed and under treatment cases of Primary Hypertension, with Blood Pressure levels either > 140 mmHg systolic or > 90 mmHg diastolic.
  • 4.Grades of Hypertension: Grade 1, 2, and 3(ESC/EHS Guidelines).
  • 5.Owning a smart phone and the ability to use it, sufficient literacy, aspiration to participate in the trial.
  • 6.With or without other comorbidities such as coronary heart disease, diabetes, hyperlipidaemia etc

排除标准

  • 1.Patients associated with any other Hypertension/Chronic Disease intervention program via digital therapeutic channels.
  • 2.Illiteracy and no ability to use smart phone.
  • 3.Bedridden and/or severely compromised patients (Chronic kidney disease, HIV, post-surgery, Covid, severe cardio pulmonary disorders etc.)
  • 4.Pre and post-partum women.
  • 5.Handicap restricting physical movements.
  • 6.Patients who received previous such digital therapeutic intervention.

研究者

发起方
Terrals Technologies Pvt Ltd

相似试验